Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGA-POWER: Somatropin in SGA Children
NCT00625872Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jul 2008
- Primary completion
- Mar 2011
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in Small for gestational age (SGA), sponsored by Pfizer. Started Jul 2008; status: terminated.
02
Drugs
somatropin
03
Conditions
Small for gestational age (SGA)
Beyond the preview
Go deeper on NCT00625872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625872.